Ellagic acid protects against cisplatin-induced nephrotoxicity in rats

A dose-dependent study

N. Al-Kharusi, H. A. Babiker, S. Al-Salam, M. I. Waly, A. Nemmar, I. Al-Lawati, J. Yasin, S. Beegam, B. H. Ali

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

BACKGROUND: The anticancer-drug cisplatin (CP) causes nephrotoxicity through different mechanisms, including generation of free radicals. Ellagic acid (EA) is a polyphenolic antioxidant found in fruits and nuts. AIM: This study aimed to investigate the ability of different doses of EA to ameliorate CP nephrotoxicity in rats. MATERIALS AND METHODS: Animals were randomly divided into six groups and treated with saline; CP alone (6 mg/kg); two doses of EA, both alone (10 and 30 mg/kg) or with CP. RESULTS: Treatment with CP alone reduced body weight, water intake, urine output, and renal total antioxidant and reduced glutathione (GSH) concentrations (p <0.01). In addition, it increased relative kidney weight, plasma creatinine, and blood urea nitrogen (BUN) concentrations (p <0.01). However, a dose of 30 mg/kg EA mitigated most of the CP-induced actions, but no effect was seen for the 10 mg/kg dose. Histopathologically, rats given CP+EA30 showed <25% necrotic lesions in the renal cortical area compared with

Original languageEnglish
Pages (from-to)299-310
Number of pages12
JournalEuropean Review for Medical and Pharmacological Sciences
Volume17
Issue number3
Publication statusPublished - 2013

Fingerprint

Ellagic Acid
Cisplatin
Kidney
Antioxidants
Nuts
Body Water
Blood Urea Nitrogen
Drinking
Free Radicals
Glutathione
Fruit
Creatinine
Body Weight
Urine
Weights and Measures

Keywords

  • Cisplatin
  • Ellagic acid
  • Nephrotoxicity
  • Rats

ASJC Scopus subject areas

  • Medicine(all)
  • Pharmacology (medical)

Cite this

Ellagic acid protects against cisplatin-induced nephrotoxicity in rats : A dose-dependent study. / Al-Kharusi, N.; Babiker, H. A.; Al-Salam, S.; Waly, M. I.; Nemmar, A.; Al-Lawati, I.; Yasin, J.; Beegam, S.; Ali, B. H.

In: European Review for Medical and Pharmacological Sciences, Vol. 17, No. 3, 2013, p. 299-310.

Research output: Contribution to journalArticle

@article{b5e3b6d8d1e04762af9e7b6548295165,
title = "Ellagic acid protects against cisplatin-induced nephrotoxicity in rats: A dose-dependent study",
abstract = "BACKGROUND: The anticancer-drug cisplatin (CP) causes nephrotoxicity through different mechanisms, including generation of free radicals. Ellagic acid (EA) is a polyphenolic antioxidant found in fruits and nuts. AIM: This study aimed to investigate the ability of different doses of EA to ameliorate CP nephrotoxicity in rats. MATERIALS AND METHODS: Animals were randomly divided into six groups and treated with saline; CP alone (6 mg/kg); two doses of EA, both alone (10 and 30 mg/kg) or with CP. RESULTS: Treatment with CP alone reduced body weight, water intake, urine output, and renal total antioxidant and reduced glutathione (GSH) concentrations (p <0.01). In addition, it increased relative kidney weight, plasma creatinine, and blood urea nitrogen (BUN) concentrations (p <0.01). However, a dose of 30 mg/kg EA mitigated most of the CP-induced actions, but no effect was seen for the 10 mg/kg dose. Histopathologically, rats given CP+EA30 showed <25{\%} necrotic lesions in the renal cortical area compared with",
keywords = "Cisplatin, Ellagic acid, Nephrotoxicity, Rats",
author = "N. Al-Kharusi and Babiker, {H. A.} and S. Al-Salam and Waly, {M. I.} and A. Nemmar and I. Al-Lawati and J. Yasin and S. Beegam and Ali, {B. H.}",
year = "2013",
language = "English",
volume = "17",
pages = "299--310",
journal = "European Review for Medical and Pharmacological Sciences",
issn = "1128-3602",
publisher = "Verduci Editore",
number = "3",

}

TY - JOUR

T1 - Ellagic acid protects against cisplatin-induced nephrotoxicity in rats

T2 - A dose-dependent study

AU - Al-Kharusi, N.

AU - Babiker, H. A.

AU - Al-Salam, S.

AU - Waly, M. I.

AU - Nemmar, A.

AU - Al-Lawati, I.

AU - Yasin, J.

AU - Beegam, S.

AU - Ali, B. H.

PY - 2013

Y1 - 2013

N2 - BACKGROUND: The anticancer-drug cisplatin (CP) causes nephrotoxicity through different mechanisms, including generation of free radicals. Ellagic acid (EA) is a polyphenolic antioxidant found in fruits and nuts. AIM: This study aimed to investigate the ability of different doses of EA to ameliorate CP nephrotoxicity in rats. MATERIALS AND METHODS: Animals were randomly divided into six groups and treated with saline; CP alone (6 mg/kg); two doses of EA, both alone (10 and 30 mg/kg) or with CP. RESULTS: Treatment with CP alone reduced body weight, water intake, urine output, and renal total antioxidant and reduced glutathione (GSH) concentrations (p <0.01). In addition, it increased relative kidney weight, plasma creatinine, and blood urea nitrogen (BUN) concentrations (p <0.01). However, a dose of 30 mg/kg EA mitigated most of the CP-induced actions, but no effect was seen for the 10 mg/kg dose. Histopathologically, rats given CP+EA30 showed <25% necrotic lesions in the renal cortical area compared with

AB - BACKGROUND: The anticancer-drug cisplatin (CP) causes nephrotoxicity through different mechanisms, including generation of free radicals. Ellagic acid (EA) is a polyphenolic antioxidant found in fruits and nuts. AIM: This study aimed to investigate the ability of different doses of EA to ameliorate CP nephrotoxicity in rats. MATERIALS AND METHODS: Animals were randomly divided into six groups and treated with saline; CP alone (6 mg/kg); two doses of EA, both alone (10 and 30 mg/kg) or with CP. RESULTS: Treatment with CP alone reduced body weight, water intake, urine output, and renal total antioxidant and reduced glutathione (GSH) concentrations (p <0.01). In addition, it increased relative kidney weight, plasma creatinine, and blood urea nitrogen (BUN) concentrations (p <0.01). However, a dose of 30 mg/kg EA mitigated most of the CP-induced actions, but no effect was seen for the 10 mg/kg dose. Histopathologically, rats given CP+EA30 showed <25% necrotic lesions in the renal cortical area compared with

KW - Cisplatin

KW - Ellagic acid

KW - Nephrotoxicity

KW - Rats

UR - http://www.scopus.com/inward/record.url?scp=84878599561&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84878599561&partnerID=8YFLogxK

M3 - Article

VL - 17

SP - 299

EP - 310

JO - European Review for Medical and Pharmacological Sciences

JF - European Review for Medical and Pharmacological Sciences

SN - 1128-3602

IS - 3

ER -